Study types
- article 6
- review 4
- other 1
- rct 1
Condition tags
- mesh:D004715 11
- endometriosis 9
- infertility 3
- adenomyosis 1
Top journals
Frequent coauthors
Gonadotropin-releasing hormone (GnRH) and its analogues have been extensively used in clinical medicine since they were identified and synthesized in 1971. Native GnRH stimulates gonadotrophs of the anterior pituitary and has been used for …
Wayne State University/Hutzel Hospital, Detroit, Michigan Correspondence: Kamran S. Moghissi, MD, Professor, Department of Obstetrics & Gynecology, Division of Reproductive Endocrinology & Infertility, Wayne State University/Hutzel Hospital…
OBJECTIVE: To determine whether hormone replacement therapy (HRT) plus goserelin (Zoladex) is as effective as goserelin alone for the relief of pelvic symptoms of endometriosis and to determine whether it reduces both the loss of bone miner…
Gonadotropin-releasing hormone (GnRH) agonists show promise as new therapeutic agents with considerable potential for clinical applications in endocrinology, gynecology, pediatrics, and oncology. GnRH agonists are derived from GnRH. This ar…
This study was designed to evaluate the effectiveness of three therapeutic modalities in the management of stage I and II endometriosis. Management modalities consisted of no treatment (controls, n = 56); oral medroxyprogesterone acetate (M…
Efficacy of oral medroxyprogesterone acetate (MPA) was assessed in 35 women with an established diagnosis of endometriosis (33 pelvic and 2 abdominal). MPA was given in a dosage of 30 mg daily for 90 days. Results indicated improvement or r…